Introduction
============

Although different organisms and organelles display minor variations with respect to the allocation of the 64 codons to the 20 amino acids ([@evu044-B21]; [@evu044-B41]), only the ensemble of 20 canonical amino acids are incorporated during translation among all known organisms. This encoded 20-amino-acid ensemble has remained immutable throughout 3 billion years of biological evolution as indicated by its universal adoption by all extant organisms. Despite the fact that amino acid analogs exist in nature, to date there is no evidence indicating that any one of the canonical amino acids has ever been completely replaced by its analog in the genetic code of an organism. However, departure from such conservation was first demonstrated experimentally by the stable mutants of parental *Bacillus subtilis* QB928 that were selected to propagate only on 4-fluorotryptophan (4FTrp), an indole-containing analog of tryptophan (Trp, [@evu044-B46]; [@evu044-B28]). In fact, for the mutant HR23 strain, the supplanted Trp acted as an inhibitory analog and caused the formation of an inhibition zone on agar gel surrounding a well-containing Trp ([@evu044-B28]). Stable mutants of QB928 that propagate successfully on 5-fuoroTrp (5FTrp) and 6-fluoroTrp (6FTrp) have also been obtained even though 4FTrp, 5FTrp, and 6FTrp are potent growth inhibitors of the parental QB928 strain. In each instance, the growth of the organism on the analog has been confirmed by protein analysis based on fluorine-19 nuclear magnetic resonance (^19^F-NMR) and high-performance liquid chromatography (HPLC) ([@evu044-B28]). 4FTrp, 5FTrp, and 6FTrp are toxic indole-containing analogs of Trp ([@evu044-B8]; [@evu044-B34]), and they can be specifically charged by *B. subtilis* Trp-tRNA synthetase to tRNA^Trp^ with reduced efficiency ([@evu044-B49]).

The mutant strains of QB928 showed that the genetic code is not an immutable construct. Instead, the invariance of its canonical amino acids during the past 3 billion years has resulted from powerful mechanisms rigorously maintaining the stability of the present day code. Although the precise mechanisms remain to be delineated, the observation that Trp can be replaced or even displaced by an analog through a small number of mutational steps suggests that oligogenic barriers comprising a limited number of proteins are involved in the obligatory usage of the canonical amino acids. Possibly, the global incorporation of an amino acid analog during translation may result in loss of protein function, reduced overall fitness, and inhibition of cell propagation. Therefore, even as benign, an analog as hydroxy-Pro has failed to supplant Pro in any known biological lineage at the level of translation. Instead, in circumstances where proteins with modified side chains are required, either posttranslational modifications or encoding of selenocysteine ([@evu044-B7]) and pyrrolysine ([@evu044-B22]; [@evu044-B33]) by stop codons have been recruited to introduce novel side chains into the proteins.

To gain insight into the validity of these plausible oligogenic barriers, we have set out in this study to characterize the genomic and transcriptomic changes occurring in five *B. subtilis* genetic code mutants of parental QB928 with varying capabilities to propagate on Trp and 4FTrp by high-throughput DNA sequencing and RNA sequencing.

Materials and Methods
=====================

Growth Curve Analysis
---------------------

The isolation of the mutant strains of Trp-auxotrophic *B. subtilis* QB928 (*aroI906 purB33 dal trpC~2~*) in [figure 1](#evu044-F1){ref-type="fig"} was described previously ([@evu044-B28]). *Bacillus subtilis* strains were first grown on 20 ml 1.6% agar plates containing Medium G (MG) ([@evu044-B46]) and 5 µg/ml Trp or 4FTrp at 37 °C. For the experiments in [figure 2](#evu044-F2){ref-type="fig"}, QB928, LC33, and TR7-1 were each grown up overnight at 37 °C, shaken at 200 rpm, and again to mid-log phase in MG supplemented with 5 µg/ml Trp, whereupon the cells were washed and allowed to resume growth under conditions 1) containing Trp only, 2) Trp and 4FTrp in 2:1 ratio, 3) Trp and 4FTrp in 1:2 ratio, and 4) containing 4FTrp only, with Trp and 4FTrp in each instance totaling 5 µg/ml. HR23, however, was grown up overnight and again to mid-log in Medium G supplemented with 5 µg/ml 4FTrp before washing and resumption of growth under conditions 1)--4). Optical density was measured on Thermo Biomate 3S at 600 nm for triplicate cultures, and the averaged measurements were fitted to Richard's curve ([@evu044-B36]) by the least squares method in Scipy package. F[ig]{.smallcaps}. 1.---Relationships of sequenced strains. Strain selection conditions are indicated, and differential propagations of each strain on Trp/4FTrp are represented by "+" or "−," where higher number of "+" symbols represents faster propagation, and \"−\" represents the inability to propagate. F[ig]{.smallcaps}. 2.---Short-term growth curves of (*A*) QB928, (*B*) LC33, (*C*) HR23, and (*D*) revertant TR7-1. The four medium G-based growth media employed differed in Trp/4FTrp contents: (i) supplemented with Trp only, (ii) Trp and 4FTrp in 2:1 ratio, (iii) Trp and 4FTrp in 1:2 ratio, and (iv) 4FTrp only.

High-Throughput DNA Sequencing
------------------------------

DNA was isolated from single-colony overnight cultures of each strain using DNAzol ([@evu044-B11]). High-throughput DNA sequencing was performed on Illumina GA IIx 75 bp paired-end platform (∼200 bp insert size) at BGI-Shenzhen (BGI) and the Genome Research Center (GRC), University of Hong Kong. Sequence libraries were prepared using Illumina kits with standard protocol. Raw sequencing reads were deposited to National Center for Biotechnology Information (NCBI) Sequence Read Archive (accession ID: SRA057077). The reads from each strain were mapped to the reference QB928 genome ([@evu044-B53]) using SHRiMP 2.1.1 ([@evu044-B14]) (-p opp-in -E -Q --single-best-mapping --half-paired). Gene annotations were originated from *B. subtilis str.168* ([@evu044-B5]), with refinements described previously ([@evu044-B53]). Sequencing depths of the different genomes are shown in [supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1) online.

Variant Calling, Annotation, and Confirmation
---------------------------------------------

Mutations were called against reference QB928 genome (GenBank: NC_018520.1) using SAMTools mpileup pipeline ([@evu044-B27]) and filtered according to the criterion of \>4 reads covered and mutant allele frequency \>0.6. Mutations were confirmed by direct visual inspection of the sequence alignment and by polymerase chain reaction followed with Sanger sequencing. In-house scripts were used to annotate amino acid changes with respect to QB928 protein sequences and the affected Pfam protein domains ([@evu044-B35]) resulting from the mutations. Mutations in intergenic regions were further annotated using DBTBS ([@evu044-B40]) to determine whether they were located within promoters, transcription factor binding sites, or terminators. To estimate the likelihood that a mutation impacted the protein functionally, predictions were made based on PROVEAN ([@evu044-B10]). Functional impact (FI) scores ≤ −2.0 are considered as deleterious, whereas FI scores \> −2.0 are considered as neutral.

RNA Sequencing
--------------

To study changes in gene expression level in Trp and 4FTrp, we have performed strand-specific RNA sequencing on all possible growth conditions of HR23, TR7, together with the parental QB928. Strand-specific paired-end library construction method was described in detail previously ([@evu044-B32]). RNA sequencing was done on the Illumina GA IIx 75 bp paired-end platform (∼200 bp insert size) at the GRC, the University of Hong Kong.

Read counts of transcripts and fragments per kilobase of transcript per million mapped reads were analyzed using Cufflinks 2.1.1([@evu044-B43]; [@evu044-B37]), followed by differential gene expression analysis using cuffdiff. Biocyc version 17 ([@evu044-B9]), and Pathway Tools 17 ([@evu044-B19]) were used to look for direct regulates of sigma factors.

Results
=======

Growth of Parental Strain and Mutants on Trp and 4FTrp
------------------------------------------------------

The isolations and phenotypes of genetic code mutants of *B. subtilis* QB928 with altered indole-amino acid requirements for propagation are shown in [figure 1](#evu044-F1){ref-type="fig"}. When monitored for cell propagation based on colony formation or ^33^P-phosphate incorporation on agar, the QB928 parental strain propagated well on Trp but not 4FTrp. QB928 gave rise serially to the LC33 mutant, which propagated on both Trp and 4FTrp, albeit slower on 4FTrp than on Trp. Further mutagenesis of LC33 gave rise to HR23, which propagated well on 4FTrp but not on Trp. However, isolates of the revertant TR7 strain derived from HR23 regained the capacity to propagate on either Trp or 4FTrp, in fact propagating faster on Trp than on 4FTrp ([@evu044-B28]).

In [figure 2](#evu044-F2){ref-type="fig"}, parental QB928 and the LC33, HR23, and TR7-1 mutants were grown in suspension in four growth media: 1) containing Trp only; 2) Trp and 4FTrp in 2:1 ratio; 3) Trp and 4FTrp in 1:2 ratio; and 4) containing 4FTrp only. The short-term growth curves observed for these strains in media 1)--4) were consistent with the relative capacities of Trp and 4FTrp to support the long-term propagation of these strains on agar ([@evu044-B28]). Thus, QB928 underwent much slower short-term biomass increase on 4FTrp in 4) compared with 1)--3) in the presence of Trp. On the other hand, LC33 underwent moderate biomass increase in all growth medium 1)--4), the rate of increase on 4FTrp being slower than that on Trp. For HR23, although there was visible short-term biomass increases in 1)--3) in the presence of Trp, these increases were smaller than that obtained in 4) in the presence of 4FTrp alone, thus showing the action of Trp as an inhibitory analog on this strain. Finally, for revertant TR7-1, the biomass increases attained in 1)--3) in the presence of Trp surpassed that in 4) in the presence of 4FTrp alone. Therefore, the genetic changes in mutants LC33, HR23, and TR7 affected both long-term cell propagation and short-term biomass increase.

Mutations Occurring between QB928 and TR7
-----------------------------------------

The mutations associated in the sequential transitions from QB928 to LC33, HR23, and finally TR7 are presented in [tables 1--3](#evu044-T1 evu044-T2 evu044-T3){ref-type="table"}. As categorized in [table 4](#evu044-T4){ref-type="table"}, the genomic sequence of LC33 displayed, in comparison to the QB928 genomic sequence ([@evu044-B53]), 5 indels and 35 base substitutions, the latter including 9 missense mutations, 2 premature terminations, 12 synonymous mutations, and 12 mutations in intergenic regions. Unlike all other mutant isolation steps in [figure 1](#evu044-F1){ref-type="fig"}, which were conducted without chemical mutagenesis, N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis was performed in mutating LC33. Therefore, not surprisingly, a much larger number of mutations were found in HR23 compared with LC33, with 9 indels and 67 base substitutions, the latter including 26 missense mutations, 6 premature terminations, and 21 synonymous mutations. Revertants TR7-1 and TR7-2, derived from HR23, each displayed only two missense mutations and one synonymous mutation; TR7-1 also showed three indels. Table 1Nonsilent Mutations Appearing in LC33 Relative to QB928[^a^](#evu044-TF2){ref-type="table-fn"}COGGeneProductTypeMutationLC33HR23TR7-1TR7-2FIC*nhaC*Na+/H+ antiporterMISSENSEAsp403Gly++++3.95E*hom*Homoserine dehydrogenaseMISSENSEAla191Val++++−3.62E*mtrB*Tryptophan operon RNA-binding attenuation protein (TRAP)NONSENSEGln47Stop++++NAK*yesS*Transcriptional regulator (AraC/XylS family)MISSENSEThr285Pro++++4.27K*ytlI*Transcriptional regulator (LysR family)MISSENSEMet6Ile++++1.13P*znuB*High affinity Zn(II) ABC transporter (permease)FRAMESHIFT INSERTIONT(514)TTC++++NAQ*srfAA*Surfactin synthetaseMISSENSEVal2743Phe++++6.78T*kinA*Sporulation-specific ATP-dependent protein histidine kinaseNONSENSELeu21Stop++++NAT*lytS*Two-component sensor histidine kinase \[LytT\]MISSENSEAla507Val++++−1.57T*prpE*Phosphorylated protein phosphatase and diadenosine-polyphosphate hydrolaseMISSENSETyr29Asn++++3.59T*resE*Two-component sensor histidine kinaseMISSENSELys252Asn++++−5.00T*resE*Two-component sensor histidine kinaseMISSENSEGln250Pro+---------−6.00[^3][^4] Table 2Nonsilent Mutations Appearing in HR23 Relative to LC33COGGeneProductTypeMutationHR23TR7-1TR7-2FIC*atpD*ATP synthase (subunit beta, component F1)MISSENSEIle175Leu+++−2.00C*cydA*Cytochrome bd ubiquinol oxidase (subunit I)MISSENSESer27Leu+++0.12C*ctaO*Protoheme IX farnesyltransferase (heme O synthase)MISSENSELeu3Pro+++−0.05C*ndh*NADH dehydrogenaseMISSENSEThr255Ile+++−4.78E*murAA*UDP-N-acetylglucosamine 1-carboxyvinyltransferaseMISSENSEMet92Leu+++−3.00E*trpE*Anthranilate synthaseMISSENSEAla466Pro+++−4.90E*yxiO*Putative efflux transporterMISSENSEAla66Thr+++−2.53F*hprT*Hypoxanthine-guanine phosphoribosyltransferaseMISSENSEAla50Thr+++−0.86J*ileS*Isoleucyl-tRNA synthetaseMISSENSEGlu814Gly+++−6.88J*infB*Initiation factor IF-2NONSENSEArg87Stop+++NAJ*infB*Initiation factor IF-2NONSENSELys85Stop+++NAJ*yugI*Putative RNA degradation protein; putative phosphorylase or nucleotidyl transferaseFRAMESHIFT INSERTIONT(251)TCAGGCGCA+++NAK*sigB*RNAP sigma-37 factor (sigma(B))MISSENSEMet64Leu+++−2.36K*sigI*RNAP sigma-I factorNONSENSEGlu23Stop+++NAK*ydeB*Putative transcriptional regulatorMISSENSEMet43Ile+++−3.13L*recA*Multifunctional SOS repair factorMISSENSEIle138Val+++−0.41L*ypsC*Putative methylase with RNA interaction domainMISSENSEGlu297Asp+++−1.33M*lytH*Sporulation-specific L-Ala-D-Glu endopeptidaseNONSENSETrp192Stop+++NAM*ytkA*Putative lipoproteinMISSENSESer110Tyr+++−2.99O*clpP*ATP-dependent Clp protease proteolytic subunitMISSENSEGly159Val+++−8.80P*perR*Transcriptional regulator (Fur family)MISSENSEThr21Ser+++−3.96P*yfiY*Putative iron(III) dicitrate transporter binding lipoproteinMISSENSESer190Tyr+++−2.46R*yabN*Putative fusion methylase and nucleotide pyrophosphohydrolaseMISSENSEAsn51Ile+++−1.40R*ybdN*Putative phage proteinMISSENSESer222Arg+++−1.81R*ydiB*Putative ATPase or kinase UPF0079MISSENSEGlu34Asp+++−2.77R*yocS*Putative sodium-dependent transporterMISSENSEMet136Ile+++−2.68R*ytkL*Putative metal-dependent hydrolaseFRAMESHIFT INSERTIONG(35)GT+++NAS*yheB*Conserved hypothetical proteinMISSENSELeu358Phe+++−3.86S*yndB*Conserved hypothetical proteinMISSENSESer75Phe+++−4.73S*yomD*Conserved hypothetical protein; phage SPbetaNONSENSELeu10Stop+++NAV*bceB*ABC transporter (permease)MISSENSEMet583Ile+++0.08V*sdpB*Exporter of killing factor SpbCMISSENSEGlu55Lys+++−0.98V*vmlR*ATP-binding cassette efflux transporterNONSENSEGly117Stop+++NAV*vmlR*ATP-binding cassette efflux transporterMISSENSEGlu120Lys+++0.30 Table 3Nonsilent Mutations Appearing in Different Isolates of TR7 Relative to HR23COGGeneProductMutation TypeMutationTR7-1TR7-2TR7-3FIK*rpoB*RNAP (β subunit)MISSENSEGlu433Lys+------−4.00K*rpoC*RNAP (β′ subunit)MISSENSEIle280Thr---+---−5.00K*rpoC*RNAP (β′ subunit)MISSENSEPro277His------+−9.00T*resD*Two-component response regulatorFRAMESHIFT INSERTIONT(245)TTA+------NAT*resD*Two-component response regulatorMISSENSEArg201Gly---+---−6.99 Table 4Overview of Mutations in Different Mutant Strains[^a^](#evu044-TF3){ref-type="table-fn"}LC33HR23TR7-1TR7-2Synonymous122111Missense92622Premature termination2600Noncoding121400Total indels5930Total substitutions356733Total mutations407663[^5]

Nonsynonymous Mutation Rate Is Not Correlated to Trp-Residue Density
--------------------------------------------------------------------

As 4FTrp was toxic to the parental QB928 strain, the selection pressure on proteins rich in Trp residues might be higher than Trp-deficient proteins, thereby accumulating a larger number of nonsynonymous mutations. Contrary to this expectation, [figure 3](#evu044-F3){ref-type="fig"} shows no significant correlation between the nonsynonymous mutation rate for genes found in the sequenced genomes and the Trp-residue density of the mutated proteins measured by WPKA, namely number of Trp residues per kilo amino acids, with Spearman correlation = 0.01 and *P* value = 0.55. Another potential mechanism for the cells to adapt to 4FTrp-supported growth might entail reduction of Trp residues in the proteome through mutations. However, [table 5](#evu044-T5){ref-type="table"} shows no significant difference between the nonsilent mutation rate of Trp residues and that of non-Trp residues in the sequenced genomes, yielding *P* value = 0.45 based on Fisher's exact test, indicating the absence of any significant difference between the two mutation rates. Therefore, it is unlikely that the selection pressure due to 4FTrp incorporation was exerted globally throughout the proteome. F[ig]{.smallcaps}. 3.---Variation of nonsynonymous point mutation frequency with tryptophan content. WPKA represents tryptophan per kilo amino acids. According to Spearman correlation test, there is no significant correlation between nonsynonymous point mutation frequency and WPKA, as indicated by ρ = 0.01 and *P* value = 0.55. Table 5Nonsilent Mutations at Trp versus Non-Trp Residues in the Combined Genomic Sequences of LC33, HR23, TR7-1, and TR7-2Original ResidueMutated ResidueUnmutated ResidueRow TotalTrp112,46412,465Non-Trp571,195,1381,195,195Column total581,207,6021,207,660[^6]

Genic Changes Enabling Cell Propagation on 4FTrp
------------------------------------------------

When parental QB928 was mutated to LC33, the ability to propagate on 4FTrp was greatly enhanced ([@evu044-B46]). In [table 1](#evu044-T1){ref-type="table"}, the conversion of QB928 to LC33 was accompanied by 12 missense, nonsense, or frameshift insertion mutations, residing in 11 different genes from six different Clusters of Orthologous Groups (COGs) ([@evu044-B42]): C---energy production and conversion; E---amino acid metabolism and transport; K---transcription; P---inorganic ion transport and metabolism; Q---secondary metabolites biosynthesis, transport and catabolism; and T---signal transduction mechanisms. Nonsense and frameshift mutations could often result in a high FI on the protein. For any missense mutation, its FI was assessed by PROVEAN ([@evu044-B10]), which measured the impact of mutations in amino acid sequences using an alignment-based score with the assumption that variations in evolutionary conserved regions would be more deleterious. A score threshold of ≤−2.0 was used to classify a variant as having potential deleterious effect. Altogether six of the mutations shown in [table 1](#evu044-T1){ref-type="table"} were potentially deleterious, being a nonsense mutation, a frameshift insertion mutation, or a missense mutation with FI ≤ −2.0.

Genic Changes Leading to Failure of Trp to Support Propagation
--------------------------------------------------------------

LC33 could propagate on Trp, but HR23 could not. In fact, Trp inhibited the growth of HR23, causing an inhibition zone on a lawn of HR23 cells on 4FTrp-supplemented agar ([@evu044-B28]). [Table 2](#evu044-T2){ref-type="table"} shows the 34 missense, nonsense, or frameshift insertion mutations in 32 genes found in the genome of HR23 relative to that of LC33. They arose in 12 different COGs: C, E, K, and P; F---nucleotide transport and metabolism; J---translation, ribosomal structure, and biogenesis; L---replication, recombination, and repair; M---cell wall/membrane/envelope biogenesis; O---posttranslational modification, protein turnover, chaperones; R---general function prediction; S---function unknown; and V---defense mechanisms. Therefore, the number of both mutated genes and COGs involved were more numerous in the conversion of LC33 to HR23 compared with the conversion of QB928 to LC33. Of these mutations, 24 of them were nonsense, frameshift insertion, or missense mutations with FI ≤ −2.0 and therefore potentially causing a significant FI.

Genetic Reversion of HR23 Cells to Support Propagation on Trp
-------------------------------------------------------------

When HR23 cells were grown as a lawn on 4FTrp-agar, the inhibition zone surrounding a well-containing Trp provided means to isolate revertants of HR23 that regained the ability to propagate on Trp, appearing as colonies inside the inhibition zone. On this basis, revertant TR7 was isolated, which propagated on Trp and 4FTrp but not on 6FTrp or 5FTrp ([@evu044-B28]). In this study, an additional revertant TR7-2 was isolated by the same procedure, and the original TR7 strain was renamed TR7-1. [Table 3](#evu044-T3){ref-type="table"} presents the mutations found in the genomes of revertants TR7-1 and TR7-2 relative to parental HR23. In both of these TR7 isolates, mutations were found in the β or β′ subunits of the RNA polymerase (RNAP), encoded by *rpoB* or *rpoC,* respectively, and in *resD* which together with its downstream *resE* gene encode the two-component signal transduction system ResDE ([@evu044-B30]). Because both TR7-1 and TR7-2 displayed mutations in the *rpo* and *resD* genes, the *rpoB, rpoC*, *resD,* and *resE* genes of an additional isolate TR7-3 were sequenced by Sanger DNA sequencing. Thereupon, TR7-3 was found to harbor a mutation in *rpoC* different from that found in TR7-2 but no mutation in either *rpoB* or *resDE.*

Expression Level of Genes Related to Trp Metabolism
---------------------------------------------------

Although none of the Trp-auxotrophic QB928 and its descendant strains in [figure 1](#evu044-F1){ref-type="fig"} could synthesize Trp or 4FTrp ([@evu044-B28]), it would be of interest to examine the regulation of genes related to Trp metabolism under conditions of Trp or 4FTrp utilization by the cells. Accordingly, transcription analysis was performed by means of RNA sequencing on QB928 growing on Trp (QB928-W cells), HR23 growing on 4FTrp (HR23-F), and TR7-1 growing on either Trp (TR7-W) or 4FTrp (TR7-F). As shown in [figure 4](#evu044-F4){ref-type="fig"} and [supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1) online, the genes related to the Trp biosynthesis pathway were overexpressed in the HR23-F, TR7-W, and TR7-F relative to QB928-W cells. In particular, the *trpEDCFBA* genes in the Trp operon were up-regulated \>4.87 log~2~-fold. The two genes that were responsible for Trp transport, *yvbW* and *trpP*, were also up-regulated 1.18--3.61 log~2~-fold in HR23-F, TR7-W, and TR7-F. These results suggest that the expressions of genes related to Trp metabolism were widely up-regulated in feedback response to growth limitation by availability of Trp or 4FTrp inside the HR23-F, TR7-W, and TR7-F cells. F[ig]{.smallcaps}. 4.---Expression fold change of (*A*) genes in Trp biosynthetic pathway and (*B*) RNAP subunits and mutated sigma factors. Log~2~-transformed expression fold changes with respect to QB928-W are shown.

Expressions of RNAP and Sigma Factors
-------------------------------------

The parental HR23 strain, which could not propagate on Trp, and its three independent TR7 revertants, which regained the ability to propagate on Trp, each contained two mutated sigma factors, namely SigB Met64Leu and SigI Glu23Stop ([table 2](#evu044-T2){ref-type="table"}). The finding that all three TR7 isolates contained a nonsilent mutation in RNAP ([table 3](#evu044-T3){ref-type="table"}) was therefore noteworthy. Because *B. subtilis* sigma factors control the specificity of RNAP toward its cognate promoters ([@evu044-B17]), the possibility has to be considered that the mutated RNAP and the mutated sigma factors might interact to determine the rejection or restoration of Trp as a propagation-supporting amino acid.

Accordingly, the mRNA levels of the mutated *rpoB*, *rpoC*, *sigB,* and *sigI* were measured along with the nonmutated *rpoA* and *rpoE* ([fig. 4](#evu044-F4){ref-type="fig"}, [supplementary table S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1) online). For *rpoB, rpoC, rpoE,* and *sigI*, only small changes in expression level were observed, where the absolute log~2~-fold changes with respect to QB928-W were \<1.3. In contrast, the expression levels of *rpoA* and *sigB* were highly up-regulated by \>2 log~2~-fold in HR23-F and TR7-F but not in TR7-W conditions ([fig. 4](#evu044-F4){ref-type="fig"}, [supplementary table S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1) online).

Discussion
==========

Postulate of Oligogenic Barriers against Amino Acid Analogs
-----------------------------------------------------------

In view of the rigorous conservation of the 20 canonical amino acids encoded by the genetic code, it was surprising that only several rounds of mutations sufficed to enable *B. subtilis* QB928 cells to propagate on the normally inhibitory Trp analogs 4FTrp, 5FTrp, and 6FTrp ([@evu044-B28]). The presence of nonsynonymous mutations among proteins also was not correlated with either the frequency of Trp residues in a protein ([fig. 3](#evu044-F3){ref-type="fig"}) or enriched at Trp residues ([table 5](#evu044-T5){ref-type="table"}). These findings suggest that the main effects of 4FTrp incorporation were localized at a small number of FTrp-sensitive proteins containing critical Trp residue(s) that underwent gross dysfunction upon substitution of Trp with FTrp, whereas the majority of Trp-containing proteins in the *B. subtilis* proteome functioned adequately with either Trp or 4FTrp (and likewise 5FTrp or 6FTrp). Accordingly, there might exist a strong oligogenic barrier, comprising a relatively small number of genes, that would ensure the maintenance of cell viability through usage of only the canonical amino acids, thereby blocking cell propagation on analogs such as the FTrps ([@evu044-B28]).

Based on this oligogenic barrier postulate, when the 4FTrp-sensitive proteins were mutated in LC33 so that the dysfunctions caused by 4FTrp incorporation were moderated, 4FTrp would become a propagation-supporting amino acid. Conversely, when one or more proteins in the LC33 proteome mutated to become sensitive to Trp, the resultant HR23 cells could propagate on 4FTrp but no longer on Trp, and Trp became thereupon an inhibitory analog of 4FTrp. In the TR7 revertants, the Trp-induced dysfunction was overcome by further mutations, and propagation on Trp was once again allowed. During biological evolution, such oligogenic barriers would channel the acquisition of beneficial novel amino acid side chains toward posttranslational modifications instead of unending expansion of the amino acid alphabet encoded by the canonical genetic code.

Clearly, the only way to test the postulated existence of oligogenic barriers as a key factor for the hitherto invariance of the canonical genetic code was to conduct an actual count of the mutations required to open up the genetic code to functionally accept an analog such as 4FTrp. Whole-genome sequencing and the tabulation of genomic alterations in the course of the transition to 4FTrp utilization, followed by Trp rejection, thus represent an important first step to elucidate the underlying mechanisms determining the capability of Trp or 4FTrp to sustain cell viability and propagation.

Mutations listed in [tables 1--3](#evu044-T1 evu044-T2 evu044-T3){ref-type="table"} inevitably contain passenger mutations that do not contribute to the oligogenic barrier significantly. In [table 1](#evu044-T1){ref-type="table"}, six of the mutations in LC33 were characterized with FI scores larger than −2.0 and therefore possibly passenger mutations because of their insignificant predicted impact. Besides, *hom* encodes homoserine dehydrogenase, which catalyzes the formation of homoserine as precursor to Thr, Ile, and Met. Because the Medium G employed in the growth and propagation of these cells was supplemented with Thr, Ile, and Met, the effects of the *hom* Ala191Val mutation might be limited. The remaining four mutated genes carrying five mutations out of a total of 4,034 protein coding genes in the genome readily met the description of an oligogenic barrier against the utilization of 4FTrp as an effective building block, the circumvention of which through mutations could serve to enhance cell propagation on 4FTrp.

HR23, derived from LC33 with the use of chemical mutagenesis during selection steps, lost the ability to propagate on Trp. In [table 2](#evu044-T2){ref-type="table"}, ten of the mutations in HR23 were characterized by an insignificant FI score of \>−2.0 and thus might be passenger mutations. Although the mutation counts in [table 1](#evu044-T1){ref-type="table"} readily validated the existence of an oligogenic barrier restricting the utility of 4FTrp for propagation of QB928, the larger number of 24 plausibly functional mutations in [table 2](#evu044-T2){ref-type="table"} suggested either 1) LC33 had to undergo a larger number of mutations to reject Trp as an effective amino acid building block or 2) the 24 mutations with FI ≤ −2.0 might include some passenger mutations on proteins possibly nonessential to cell propagation.

As expected, mutations in genes related to Trp metabolism and stress response can be found, but we also observed numerous mutations in the transcription and translation machinery. Among the latter 24 mutations, the Glu814Gly mutation of IleRS was intriguing insofar that Ile activation was functionally removed from TrpRS activity. However, IleRS has a proofreading domain ([@evu044-B18]), and it would be of interest to determine whether this mutation could affect the defense of IleRS against inhibition or mischarging by 4FTrp, which is more hydrophobic than Trp with a ΔΔ*G* of 0.42 kcal/mol for transfer from n-octanol to water ([@evu044-B49]). The *ydiB* gene product, based on the latest annotation of *B. subtilis str.BSU168* genome ([@evu044-B6]), is responsible for the biosynthesis of the modified nucleoside threonylcarbamoyladensoine on tRNAs ([@evu044-B20]; [@evu044-B25]) and could play an important role in the fine tuning of translation.

In contrast to the 24 plausibly functional mutations that accompanied the transition from LC33 to HR23 and the rejection of Trp as a canonical amino acid, the two nonsilent mutations displayed by each of the revertants TR7-1 and TR7-2 relative to HR23 ([table 3](#evu044-T3){ref-type="table"}) revealed that a maximum of two mutations sufficed to break down the barrier in HR23 against cell propagation on Trp, restoring to TR7-1 the capacity to propagate on Trp, in fact 40% faster than propagation on 4FTrp ([@evu044-B28]). The paucity of mutations displayed by TR7-1 and TR7-2 strongly supported the postulate of oligogeneic barriers as a key factor in rigorously preserving the composition of the canonical amino acid alphabet of the genetic code.

Expression of Genes Related to Trp Transport and Biosynthesis
-------------------------------------------------------------

Previously, we observed that a Ser82Leu mutation on the *trpS* gene of *B. subtilis* for Trp-tRNA synthetase conferred resistance to growth inhibition by 5FTrp ([@evu044-B12]). In contrast, although the transition of QB928 successively to LC33, HR23, and finally TR7 involved at each stage an alteration in the Trp/4FTrp propagation ratio, there was no mutation in *trpS* gene in [tables 1](#evu044-T1){ref-type="table"}, [2](#evu044-T2){ref-type="table"}, or [3](#evu044-T3){ref-type="table"}.

In contrast, the *mtrB* gene for the Trp operon RNA-binding attenuation protein (TRAP) underwent a Gln47Stop nonsense mutation near the N-terminus of the protein in LC33, which persisted in HR23, TR7-1, and TR7-2. TRAP is responsible for both transcription attenuation of Trp operon ([@evu044-B16]; [@evu044-B52]) and translational repression of *trpG, trpP,* and *ycbK* ([@evu044-B15]; [@evu044-B39]; [@evu044-B51], [@evu044-B50]), and *mtrB* knockouts enhanced 5FTrp resistance ([@evu044-B16]). In *Escherichia coli,* a nonsense mutation in the aromatic amino acid regulon repressor *tyrR*, which is structurally and functionally similar to *mtrB*, also enhanced resistance of 4FTrp ([@evu044-B3]). Thus, the Gln47Stop mutation in MtrB would help to explain the extensively elevated expression of the Trp transporter and Trp biosynthetic genes in HR23 growing on 4FTrp and TR7-1 growing on either Trp or 4FTrp. Notably, the elevated expression of Trp transporters could improve cell growth on Trp or 4FTrp, but the elevated expression of Trp biosynthetic genes would be futile on account of the *aroI906, trpC~2~* mutations rendering QB928, and all its derivative strains incapable of Trp biosynthesis.

RNAP Mutations
--------------

HR23 could not propagate on Trp, but its TR7 revertants could do so. Upon sequencing, the genomes of the independent isolates TR7-1 and TR7-2 each yielded only two nonsilent mutations relative to the HR23 genome, namely Glu433Lys of RpoB and T(245)TTA of *resD* in TR7-1, and Ile280Thr of RpoC and Arg201Gly of ResD in TR7-2. In view of these results, the *rpoB*, *rpoC*, *resD,* and *resE* genes of a third independent revertant TR7-3 were also sequenced, which yielded a Pro277His mutation in RpoC but no mutation in either *rpoB* or *resD* ([table 3](#evu044-T3){ref-type="table"}). These findings indicated that *rpoBC* were candidate genes where appropriate mutations could determine the acceptability versus rejection of Trp as a canonical amino acid.

Bacterial gene expression is dependent on the interaction between RNAP and different promoters, assisted in some cases by activator or repressor proteins ([@evu044-B17]). Different sigma factors can bind to the core RNAP subunits and modify the specificity of the α~2~ββ′ω RNAP ([@evu044-B13]; [@evu044-B23], [@evu044-B24]). Of the three missense RNAP mutations shown in [table 3](#evu044-T3){ref-type="table"}, one occurs on the β subunit and two on the β′ subunit. The β-Glu433, β′-Ile280, and β′-Pro277 residues involved are all strongly or totally conserved on the bacterial RNAP subunit sequences aligned in [figure 5](#evu044-F5){ref-type="fig"}. Accordingly, the three mutations β-Glu433Lys, β′-Ile280Thr, and β′-Pro277His are characterized by the highly significant FI values of −4.00, −5.00, and −9.00, respectively. These three mutations were in fact not found on any of 960 RpoB and 844 RpoC sequences in the NCBI nonredundant protein database. The uniqueness of these mutations suggested that an extreme modification of the RNAP molecule was required to overcome the mutation(s) that effectively blocked cell propagation on Trp. Among the six Trp residues in the β subunit and seven Trp residues in the β′ subunit (marked in magenta in [figure 6](#evu044-F6){ref-type="fig"}), two universally conserved Trp residues in bacterial RNAP, namely β-Trp1081 and β′-Trp105, are located in the lobe domain and clamp domain of RNAP, respectively ([@evu044-B13]; [@evu044-B24]). These two residues, and the other Trp residues in the two subunits, would merit investigation as potentially Trp-sensitive residues in RNAP in HR23. F[ig]{.smallcaps}. 5.---Multiple sequence alignment of bacterial RNAP β subunit (part *A*) and β′ subunit (part *B*). Portions of the full multiple sequence alignments of RpoB sequences from 960 bacterial strains and of RpoC sequences from 844 bacterial strains, identified by BlastP against NCBI nonredundant protein database, are shown. The mutated positions in strains TR7-1, TR7-3, and TR7-2 are marked by arrows with the respectively mutated residues K, H, and T indicated above the arrows. Because none of the mutated K, H, and T residues is found in the full multiple sequence alignments, their occurrences in the TR7 revertants are unique among reported bacterial RpoB and RpoC sequences. F[ig]{.smallcaps}. 6.---*Escherichia coli* RNAP transcription elongation complex (TEC) model ([@evu044-B31]). RNAP β subunit is shown in yellow, β′ subunit in blue, Trp residues in magenta, and mutated residues in the independent isolates TR7-1, TR7-2, and TR7-3 in red within the green box. All three mutations are located at the outer claw-like region, one on the β subunit and two on the β′ subunit. The two universally conserved Trp residues, namely β-Trp1081 and β′-Trp105, are marked with green arrows. Distances in Ångström between the mutated K, H, and T residues are K-H 29.7 Å, K-T 24.0 Å, and H-T 13.7 Å, respectively.

In this regard, [table 2](#evu044-T2){ref-type="table"} showed that the transition of LC33 to HR23 was accompanied by two mutations in sigma factors, which were carried over to both TR7-1 and TR7-2, namely Met64Leu in SigB and Glu23Stop in SigI. Accordingly, the modifications of RNAP exhibited by TR7-1, TR7-2, and TR7-3 could stem from the SigB Met64Leu and/or SigI Glu23Stop mutations. [Supplementary table S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1) online, shows that, relative to QB928 cells growing on Trp, SigI level did not change greatly in HR23 cells growing on 4FTrp, or in TR7-1 cells growing on either Trp or 4FTrp. On the other hand, the expression level of SigB was increased by \>2 log~2~-fold when HR23 or TR7-1 cells were grown on 4FTrp, suggesting that there could be some inadequacy in SigB performance inside these cells.

Consequently, the possibility exists that the SigB Met64Leu and/or SigI Glu23Stop mutations in HR23 was a major contributor to the failure of Trp to support cell propagation owing to inefficient interaction between α~2~ββ′ω RNAP and SigB and/or SigI, and this failure was remedied by the β-Glu433Lys, β′-Ile280Thr, or β′-Pro277His mutation displayed by TR7-1, TR7-2, and TR7-3, respectively. As shown in [figure 6](#evu044-F6){ref-type="fig"}, this possibility is supported by the locations of these three mutations on the two sides of the conserved claw-like region on RNAP where sigma factor binds ([@evu044-B1]; [@evu044-B29]; [@evu044-B44]). At their locations, each of these three mutations could be well positioned to rectify a malformation of the RNAP-SigB complex caused by the incorporation of Trp into RNAP or SigB or alleviate the dependence of essential RNAP functions on SigI, which would be knocked out by the Glu23Stop nonsense mutation near its N-terminus.

In conclusion, the invariance of the canonical amino acid alphabet throughout biological evolution has now been broken with the isolation of the *B. subtilis* QB928 genetic code mutants ([fig. 1](#evu044-F1){ref-type="fig"}), where the ability of Trp to support growth can be reversibly displaced by 4FTrp. These findings have laid the foundation for synthetic lifeforms ([@evu044-B47]). Moreover, the mutability of this canonical alphabet has since been confirmed by the development of additional approaches to introduce unnatural amino acids into proteomes, including the use of the thymidine auxotrophic *E. coli* R126L mutant where the analog azaleucine must be supplied to the cells to support growth in the absence of added thymidine ([@evu044-B26]), the propagation of unColi strains and their phages on fluoroTrps ([@evu044-B3]; [@evu044-B2], [@evu044-B4]), and the incorporation of a wide array of amino acid analogs via orthogonal pairs of tRNA and amino acyl-tRNA synthetase ([@evu044-B45]; [@evu044-B38]; [@evu044-B48]). However, the mechanisms preserving the remarkable universality of the canonical amino acids encoded by the genetic code have remained largely unfathomed. In this regard, this study has provided strong evidence for oligogenic barriers encoding a small number of analog-sensitive proteins as a key factor in safeguarding the canonical alphabet throughout biological evolution. Notably, for Trp with its unique indole side chain, the number of metabolite analogs that could mount a challenge against its tenure as canonical amino acid through their activation by TrpRS and attachment to tRNA^Trp^ would be few. As a result, there was no need for the oligogenic barrier protecting the long lasting membership of Trp to include the TrpRS-encoding *trpS* gene, and [tables 1](#evu044-T1){ref-type="table"} and [2](#evu044-T2){ref-type="table"} did not include any mutation of *trpS*. With a canonical amino acid such as Ile with a chemically less unique side chain, its cognate IleRS often has to be equipped with a proofreading domain to protect against mischarging of tRNA^Ile^ by Ile analogs. Therefore, the proofreading domain of IleRS may well be part of the oligogenic barrier for Ile that must be mutated to allow replacement or displacement of Ile from the genetic code by Ile analogs. Clearly, the oligogenic barrier will vary with both the canonical amino acid and the analog challenger.

In any event, a thorough understanding of the mechanisms upholding the canonical alphabets of proteins and nucleic acids in the living world, as well as other universally adopted building blocks and cofactors, will be required both to advance insights into the chemical parameters that shaped the living world and to enhance medicine and bioengineering through the design and introduction of additional building blocks.

Supplementary Material
======================

[Supplementary tables S1--S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu044/-/DC1) are available at *Genome Biology and Evolution* online (<http://www.gbe.oxfordjournals.org/>).
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[^1]: **Associate editor:** Laura Landweber

[^2]: **Data deposition:** Raw sequencing reads have been deposited at NCBI Sequence Read Archive under the accession SRA057077. Reference QB928 genome (GenBank: NC_018520.1).

[^3]: N[ote]{.smallcaps}.---NA indicates FI was not analyzed. For insertions, the inserted base is denoted in parentheses.

[^4]: ^a^FI was determined using PROVEAN ([@evu044-B10]). FI scores ≤ −2 are considered as deleterious, whereas FI scores \> −2 are considered as neutral.

[^5]: ^a^Mutations in LC33 were scored with respect to QB928; ones in HR23 scored with respect to LC33; and ones in TR7-1 or TR7-2 scored with respect to HR23.

[^6]: N[ote]{.smallcaps}.---Based on Fisher's exact test, no significant difference between the two mutation rates were observed, as indicated by *P* value = 0.45.
